Anavex Life Sciences
AVXL
#7563
Rank
$0.39 B
Marketcap
$4.40
Share price
-1.12%
Change (1 day)
-42.11%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -$52.05 Million USD

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$51.56 Million USD a decrease over its 2023 earnings that were of -$44.93 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$52.05 Million0.96%
2024 -$51.56 Million14.77%
2023 -$44.93 Million-17.49%
2022 -$54.45 Million22.96%
2021 -$44.28 Million35.36%
2020 -$32.71 Million12.65%
2019 -$29.04 Million29.09%
2018 -$22.5 Million36.33%
2017 -$16.5 Million17.11%
2016 -$14.09 Million20.91%
2015 -$11.66 Million-6.29%
2014 -$12.44 Million337.28%
2013 -$2.85 Million
2008 -$5.26 Million106.01%
2007 -$2.56 Million8848.98%
2006 -$0.03 Million-79.99%
2005 -$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
$66.79 M-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$6.62 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
$65.57 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$17.3 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA